Potential of transglutaminase 2 as a therapeutic target. - Wikidata - awgldk - TriplyDB

Potential of transglutaminase 2 as a therapeutic target.

Potential of transglutaminase 2 as a therapeutic target.

http://www.wikidata.org/entity/Q37776508

about

Involvement of IL-13 and tissue transglutaminase in liver granuloma and fibrosis after schistosoma japonicum infection Biological Significance of Local TGF-β Activation in Liver Diseases.γ-Glutamylamines and neurodegenerative diseases The Different Conformational States of Tissue Transglutaminase Have Opposing Affects on Cell Viability.Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration.Transglutaminase 2 and neuroinflammation.Transglutaminase inhibitors: a patent review.Modulation of transglutaminase 2 activity in H9c2 cells by PKC and PKA signalling: a role for transglutaminase 2 in cytoprotection.Anti-cancer effect of a quinoxaline derivative GK13 as a transglutaminase 2 inhibitor.Transglutaminase 2 expression is enhanced synergistically by interferon-γ and tumour necrosis factor-α in human small intestine.Identification of human salivary transglutaminases.Synthesis and Kinetic Characterisation of Water-Soluble Fluorogenic Acyl Donors for Transglutaminase 2.

P2860

Q33930636-14A05AB3-22F7-4E76-8D2F-78AAAE09C3BB Q35750103-04689EC4-BD14-4C37-8704-E9D22C78F966 Q36377238-3FAB36C4-B4EB-49E1-B09F-40698F463111 Q36884822-B6828A4F-9A0C-4369-B43B-6726285A04A8 Q37029655-C836EC2D-6920-4F12-8651-A031EB0C4A5A Q38268274-C78268EC-82EA-419F-867E-887E70FB8CEB Q38631307-8A5ABAC5-68F1-44E3-9ED0-C2FBF590CEBC Q38995669-FE887312-1DED-40FE-8AA5-B22FFCB159A7 Q39162858-06F69138-7B05-41B4-A150-C90F0A323057 Q39386727-31A96021-7B00-44AF-8D10-29BCA6EED47B Q39687501-6A874BDF-23D2-4AB9-8E02-D8A21A37B350 Q53764493-9DDBD2AA-9223-4A22-A64E-565D1A74B292

P2860

Potential of transglutaminase 2 as a therapeutic target.

http://www.wikidata.org/entity/Q37776508

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Potential of transglutaminase 2 as a therapeutic target.

@en

Potential of transglutaminase 2 as a therapeutic target.

@nl

type

label

Potential of transglutaminase 2 as a therapeutic target.

@en

Potential of transglutaminase 2 as a therapeutic target.

@nl

prefLabel

Potential of transglutaminase 2 as a therapeutic target.

@en

Potential of transglutaminase 2 as a therapeutic target.

@nl

P1433

Q37776508-ED19B08E-2F63-4E2D-87D1-1235C9E288D2

P1476

Q37776508-7529D246-1BBF-4F76-A374-73F3D13C0C2D

P2093

Q37776508-3C9689C1-7EEE-4C69-9410-EA6DD15793DC

Q37776508-633C04EE-3410-4B88-94D1-88E63E07B307

Q37776508-69C97D6B-4392-4095-A4AE-6C4AECCDFFFE

P2860

Q37776508-018EE233-174C-4871-BA8F-89051D7E141E

Q37776508-0AB473C2-527E-48B2-A700-8E06C2559145

Q37776508-101F53EE-CB1C-4F43-BECE-235E2CC4D200

Q37776508-15C4557B-F783-4896-94D5-61298A1DD4C1

Q37776508-15DDD66A-1659-4C4F-840D-667CC64949C8

Q37776508-19472D87-B248-4399-8A6A-A1E0A0072597

Q37776508-1E0207A3-C51B-412C-9F97-C5E93D8B875F

Q37776508-215A05C2-5355-455C-847E-60551105F1ED

Q37776508-243D63D1-B18B-4120-9060-10BEB67614ED

Q37776508-27DB1E12-82B4-4957-A9B3-EF4B23EC0531

P304

Q37776508-B8DFDDDB-EC4A-4BFB-86E2-04FC1D358C68

P31

Q37776508-C64928AB-4339-48FB-808E-8551A7DBBE50

P356

Q37776508-CA38C635-659F-4C44-BD90-089CEE705527

P407

Q37776508-0BD3E90D-6DB0-439E-AC30-824A128BA416

P433

Q37776508-9FEDE5A8-013A-4C63-9FF1-6944FBD031C9

P478

Q37776508-A2443F65-FCE8-4D9C-BFAC-49C0B774F5B9

P50

Q37776508-17485930-FAD9-46EE-BEC6-240E45317317

Q37776508-25EAB359-C2C0-42A5-95D5-AC3915873802

Q37776508-E50E4038-0FBE-43EA-A097-B456B152923D

P577

Q37776508-A8D0F8F4-2474-438D-A250-C67EB9244585

P698

Q37776508-28F8E2CF-B164-405B-A970-D3E191B5A511

P356

14728222.2010.510134

P1433

Expert Opinion on Therapeutic Targets

P1476

Potential of transglutaminase 2 as a therapeutic target

@en

P2093

Daniela Caccamo

http://www.w3.org/2001/XMLSchema#string

Monica Currò

http://www.w3.org/2001/XMLSchema#string

Riccardo Ientile

http://www.w3.org/2001/XMLSchema#string

P2860

Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway

Transglutaminases: nature's biological glues

Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes

The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase

Transglutaminase 2: an enigmatic enzyme with diverse functions

Identification of tissue transglutaminase as the autoantigen of celiac disease

Tissue transglutaminase contributes to disease progression in the R6/2 Huntington's disease mouse model via aggregate-independent mechanisms

Cystamine inhibits transglutaminase and caspase-3 cleavage in glutamate-exposed astroglial cells.

Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries.

Synthesis of potent water-soluble tissue transglutaminase inhibitors.

P304

989-1003

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728222.2010.510134

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Riccardo Ientile

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20670177

http://www.w3.org/2001/XMLSchema#string